| Name | SARS-CoV-2-IN-11 |
|---|
| Description | SARS-CoV-2-IN-11 is a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease (3CLpro) with an IC50 and EC50 of 0.17 and 1.45 nM, respectively. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for therapeutic intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals[1]. |
|---|---|
| Related Catalog | |
| Target |
SARS-CoV-2 3C-like proteas[1] |
| References |
| Molecular Formula | C27H38F2N3NaO8S |
|---|---|
| Molecular Weight | 625.66 |